Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Malignant Melanoma

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 171 articles:
HTML format

Single Articles

    January 2020
  1. FLEM-KARLSEN K, Nyakas M, Farstad IN, McFadden E, et al
    Soluble AXL as a marker of disease progression and survival in melanoma.
    PLoS One. 2020;15:e0227187.
    PubMed     Abstract available

  2. MIHAILOVIC DT, Petric D, Petrovic T, Hrnjakovic-Cvjetkovic I, et al
    Assessment of climate change impact on the malaria vector Anopheles hyrcanus, West Nile disease, and incidence of melanoma in the Vojvodina Province (Serbia) using data from a regional climate model.
    PLoS One. 2020;15:e0227679.
    PubMed     Abstract available

  3. APLAK E, von Montfort C, Haasler L, Stucki D, et al
    CNP mediated selective toxicity on melanoma cells is accompanied by mitochondrial dysfunction.
    PLoS One. 2020;15:e0227926.
    PubMed     Abstract available

  4. SEVILLA A, Morales MC, Ezkurra PA, Rasero J, et al
    BRAF V600E mutational load as a prognosis biomarker in malignant melanoma.
    PLoS One. 2020;15:e0230136.
    PubMed     Abstract available

  5. DELEON TT, Almquist DR, Kipp BR, Langlais BT, et al
    Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.
    PLoS One. 2020;15:e0230306.
    PubMed     Abstract available

  6. HU Z, Yu P, Du G, Wang W, et al
    PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.
    PLoS One. 2020;15:e0228339.
    PubMed     Abstract available

  7. HIRSHOREN N, Yoeli R, Cohen JE, Weinberger JM, et al
    Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.
    PLoS One. 2020;15:e0231038.
    PubMed     Abstract available

  8. VARIN J, Reynolds MM, Bouzidi N, Tick S, et al
    Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.
    PLoS One. 2020;15:e0231750.
    PubMed     Abstract available

  9. Correction: Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.
    PLoS One. 2020;15:e0233424.
    PubMed     Abstract available

  10. SZTWIERTNIA I, Schenz J, Bomans K, Schaack D, et al
    Sevoflurane depletes macrophages from the melanoma microenvironment.
    PLoS One. 2020;15:e0233789.
    PubMed     Abstract available

  11. BUSS LA, Ang AD, Hock B, Robinson BA, et al
    Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice.
    PLoS One. 2020;15:e0229290.
    PubMed     Abstract available

  12. GRZYWA TM, Klicka K, Paskal W, Dudkiewicz J, et al
    miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma.
    PLoS One. 2020;15:e0234707.
    PubMed     Abstract available

  13. SO AR, Si JM, Lopez D, Pellegrini M, et al
    Molecular signatures for inflammation vary across cancer types and correlate significantly with tumor stage, sex and vital status of patients.
    PLoS One. 2020;15:e0221545.
    PubMed     Abstract available

  14. SALGADO C, Roelse C, Nell R, Gruis N, et al
    Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.
    PLoS One. 2020;15:e0231418.
    PubMed     Abstract available

  15. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available

  16. BALLESTEROS-ALVAREZ J, Dilshat R, Fock V, Moller K, et al
    MITF and TFEB cross-regulation in melanoma cells.
    PLoS One. 2020;15:e0238546.
    PubMed     Abstract available

  17. ALI AR, Li J, O'Shea SJ
    Towards the automatic detection of skin lesion shape asymmetry, color variegation and diameter in dermoscopic images.
    PLoS One. 2020;15:e0234352.
    PubMed     Abstract available

    January 2019
  18. HUGDAHL E, Bachmann IM, Schuster C, Ladstein RG, et al
    Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.
    PLoS One. 2019;14:e0210399.
    PubMed     Abstract available

  19. BASILE MS, Mazzon E, Russo A, Mammana S, et al
    Differential modulation and prognostic values of immune-escape genes in uveal melanoma.
    PLoS One. 2019;14:e0210276.
    PubMed     Abstract available

  20. WODLEJ C, Riedl S, Rinner B, Leber R, et al
    Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
    PLoS One. 2019;14:e0211187.
    PubMed     Abstract available

  21. PO JW, Ma Y, Balakrishna B, Brungs D, et al
    Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status.
    PLoS One. 2019;14:e0211866.
    PubMed     Abstract available

  22. SUROWKA G, Ogorzalek M
    Resolution invariant wavelet features of melanoma studied by SVM classifiers.
    PLoS One. 2019;14:e0211318.
    PubMed     Abstract available

  23. VAN LAAR R, Lincoln M, Fereday S
    Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma.
    PLoS One. 2019;14:e0211504.
    PubMed     Abstract available

  24. SHAHRIYARI L, Abdel-Rahman M, Cebulla C
    BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    PLoS One. 2019;14:e0211507.
    PubMed     Abstract available

  25. CHO SI, Lee J, Jo G, Kim SW, et al
    Local recurrence and metastasis in patients with malignant melanomas after surgery: A single-center analysis of 202 patients in South Korea.
    PLoS One. 2019;14:e0213475.
    PubMed     Abstract available

  26. KOBAYASHI M, Kato T, Washiyama K, Ihara M, et al
    The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to alpha-melanocyte-stimulating hormone analogues for melanoma imaging.
    PLoS One. 2019;14:e0213397.
    PubMed     Abstract available

  27. LIU X, Zhang Q, Fan C, Tian J, et al
    GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma.
    PLoS One. 2019;14:e0214073.
    PubMed     Abstract available

  28. CONSOLI F, Manganoni AM, Grisanti S, Petrelli F, et al
    Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy.
    PLoS One. 2019;14:e0214884.
    PubMed     Abstract available

  29. WU S, Naar AM
    A lipid-free and insulin-supplemented medium supports De Novo fatty acid synthesis gene activation in melanoma cells.
    PLoS One. 2019;14:e0215022.
    PubMed     Abstract available

  30. DATAR I, Kalpana G, Choi J, Basuroy T, et al
    Critical role of miR-10b in B-RafV600E dependent anchorage independent growth and invasion of melanoma cells.
    PLoS One. 2019;14:e0204387.
    PubMed     Abstract available

  31. MANNINEN AA, Gardberg M, Juteau S, Ilmonen S, et al
    BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas.
    PLoS One. 2019;14:e0216043.
    PubMed     Abstract available

  32. YAN Y, Leontovich AA, Gerdes MJ, Desai K, et al
    Understanding heterogeneous tumor microenvironment in metastatic melanoma.
    PLoS One. 2019;14:e0216485.
    PubMed     Abstract available

  33. VON HACHT JL, Erdmann S, Niederstadt L, Prasad S, et al
    Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
    PLoS One. 2019;14:e0217883.
    PubMed     Abstract available

  34. KOS S, Lopes A, Preat V, Cemazar M, et al
    Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.
    PLoS One. 2019;14:e0217762.
    PubMed     Abstract available

  35. LI Y, Li M, Shats I, Krahn JM, et al
    Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    PLoS One. 2019;14:e0218067.
    PubMed     Abstract available

  36. VALLEE A, Denis-Musquer M, Herbreteau G, Theoleyre S, et al
    Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay.
    PLoS One. 2019;14:e0221123.
    PubMed     Abstract available

  37. BOCHEM J, Zelba H, Amaral T, Spreuer J, et al
    Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
    PLoS One. 2019;14:e0221301.
    PubMed     Abstract available

  38. Correction: Differential roles of gangliosides in malignant properties of melanomas.
    PLoS One. 2019;14:e0222220.
    PubMed     Abstract available

  39. BERNING L, Scharf L, Aplak E, Stucki D, et al
    In vitro selective cytotoxicity of the dietary chalcone cardamonin (CD) on melanoma compared to healthy cells is mediated by apoptosis.
    PLoS One. 2019;14:e0222267.
    PubMed     Abstract available

  40. AGNARSDOTTIR M, Popova S, Alafuzoff I
    Expression of CMV protein pp65 in cutaneous malignant melanoma.
    PLoS One. 2019;14:e0223854.
    PubMed     Abstract available

  41. PILCH Z, Tonecka K, Skorzynski M, Sas Z, et al
    The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies.
    PLoS One. 2019;14:e0210796.
    PubMed     Abstract available

  42. ZHENG H, Liu L, Zhang H, Kan F, et al
    Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses.
    PLoS One. 2019;14:e0211490.
    PubMed     Abstract available

  43. PERLSTEIN D, Shlagman O, Kogan Y, Halevi-Tobias K, et al
    Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug.
    PLoS One. 2019;14:e0226869.
    PubMed     Abstract available

  44. KATO Y, Tabata K, Kimura T, Yachie-Kinoshita A, et al
    Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
    PLoS One. 2019;14:e0212513.
    PubMed     Abstract available

  45. CHRISTENSEN MB, Wadt K, Jensen UB, Lautrup CK, et al
    Exploring the hereditary background of renal cancer in Denmark.
    PLoS One. 2019;14:e0215725.
    PubMed     Abstract available

  46. YAMAUCHI I, Yasoda A, Matsumoto S, Sakamori Y, et al
    Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
    PLoS One. 2019;14:e0216954.
    PubMed     Abstract available

  47. HOSNY KM, Kassem MA, Foaud MM
    Classification of skin lesions using transfer learning and augmentation with Alex-net.
    PLoS One. 2019;14:e0217293.
    PubMed     Abstract available

  48. RABIN-COURT A, Rodrigues MR, Zhang XM, Perry RJ, et al
    Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
    PLoS One. 2019;14:e0218126.
    PubMed     Abstract available

  49. BRINKER TJ, Hekler A, Enk AH, von Kalle C, et al
    Enhanced classifier training to improve precision of a convolutional neural network to identify images of skin lesions.
    PLoS One. 2019;14:e0218713.
    PubMed     Abstract available

  50. BEENAKKER JM, Wezel J, Groen J, Webb AG, et al
    Silent volumetric multi-contrast 7 Tesla MRI of ocular tumors using Zero Echo Time imaging.
    PLoS One. 2019;14:e0222573.
    PubMed     Abstract available

  51. OHIRA T, Kojima H, Kuroda Y, Aoki S, et al
    PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription.
    PLoS One. 2019;14:e0217605.
    PubMed     Abstract available

  52. YLOSMAKI L, Polini B, Carpi S, Martins B, et al
    Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.
    PLoS One. 2019;14:e0224072.
    PubMed     Abstract available

  53. ALSHURAFA N, Jain J, Stump TK, Spring B, et al
    Assessing recall of personal sun exposure by integrating UV dosimeter and self-reported data with a network flow framework.
    PLoS One. 2019;14:e0225371.
    PubMed     Abstract available

    January 2018
  54. OLIVAN-VIGUERA A, Garcia-Otin AL, Lozano-Gerona J, Abarca-Lachen E, et al
    Pharmacological activation of TRPV4 produces immediate cell damage and induction of apoptosis in human melanoma cells and HaCaT keratinocytes.
    PLoS One. 2018;13:e0190307.
    PubMed     Abstract available

  55. JAROSZ-BIEJ M, Kaminska N, Matuszczak S, Cichon T, et al
    M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
    PLoS One. 2018;13:e0191012.
    PubMed     Abstract available

  56. CRONIN JC, Loftus SK, Baxter LL, Swatkoski S, et al
    Identification and functional analysis of SOX10 phosphorylation sites in melanoma.
    PLoS One. 2018;13:e0190834.
    PubMed     Abstract available

  57. WANG LX, Li Y, Chen GZ
    Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
    PLoS One. 2018;13:e0190447.
    PubMed     Abstract available

  58. ERNST AK, Putscher A, Samatov TR, Suling A, et al
    Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
    PLoS One. 2018;13:e0192525.
    PubMed     Abstract available

  59. JOSHI SS, Jiang S, Unni E, Goding SR, et al
    17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.
    PLoS One. 2018;13:e0191264.
    PubMed     Abstract available

  60. YU C, Yang S, Kim W, Jung J, et al
    Acral melanoma detection using a convolutional neural network for dermoscopy images.
    PLoS One. 2018;13:e0193321.
    PubMed     Abstract available

  61. SHANKAR BABU M, Mahanta S, Lakhter AJ, Hato T, et al
    Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.
    PLoS One. 2018;13:e0191419.
    PubMed     Abstract available

  62. DEIKE-HOFMANN K, Thunemann D, Breckwoldt MO, Schwarz D, et al
    Sensitivity of different MRI sequences in the early detection of melanoma brain metastases.
    PLoS One. 2018;13:e0193946.
    PubMed     Abstract available

  63. NAGANE M, Kanai E, Shibata Y, Shimizu T, et al
    Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma.
    PLoS One. 2018;13:e0195151.
    PubMed     Abstract available

  64. PRITCHARD AL, Johansson PA, Nathan V, Howlie M, et al
    Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
    PLoS One. 2018;13:e0194098.
    PubMed     Abstract available

  65. LIU H, Weber A, Morse J, Kodumudi K, et al
    T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model.
    PLoS One. 2018;13:e0196033.
    PubMed     Abstract available

  66. YU C, Yang S, Kim W, Jung J, et al
    Correction: Acral melanoma detection using a convolutional neural network for dermoscopy images.
    PLoS One. 2018;13:e0196621.
    PubMed     Abstract available

  67. HUANG YX, Song H, Tao Y, Shao XB, et al
    Ovostatin 2 knockdown significantly inhibits the growth, migration, and tumorigenicity of cutaneous malignant melanoma cells.
    PLoS One. 2018;13:e0195610.
    PubMed     Abstract available

  68. AUGUSTIN M, Blome C, Forschner A, Gutzmer R, et al
    Willingness to pay for a cure of low-risk melanoma patients in Germany.
    PLoS One. 2018;13:e0197780.
    PubMed     Abstract available

  69. KEELEY T, Lin S, Lester DK, Lau EK, et al
    The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.
    PLoS One. 2018;13:e0199128.
    PubMed     Abstract available

  70. BUONTEMPO F, Orsini E, Zironi I, Isolan L, et al
    Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.
    PLoS One. 2018;13:e0199312.
    PubMed     Abstract available

  71. FLEMING NH, Grade MM, Bendavid E
    Impact of primary care provider density on detection and diagnosis of cutaneous melanoma.
    PLoS One. 2018;13:e0200097.
    PubMed     Abstract available

  72. UHRIG M, Simons D, Schlemmer HP
    Incidental pulmonary emboli in stage IV melanoma patients: Prevalence in CT staging examinations and improved detection with vessel reconstructions based on dual energy CT.
    PLoS One. 2018;13:e0199458.
    PubMed     Abstract available

  73. NAIR-SHALLIKER V, Egger S, Chrzanowska A, Mason R, et al
    Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels.
    PLoS One. 2018;13:e0193893.
    PubMed     Abstract available

  74. LADDS MJGW, Pastor-Fernandez A, Popova G, van Leeuwen IMM, et al
    Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib.
    PLoS One. 2018;13:e0195956.
    PubMed     Abstract available

  75. LIU ZJ, Zhou YJ, Ding RL, Xie F, et al
    In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
    PLoS One. 2018;13:e0200845.
    PubMed     Abstract available

  76. TARIQ H, Eldridge E, Welch I
    An efficient approach for feature construction of high-dimensional microarray data by random projections.
    PLoS One. 2018;13:e0196385.
    PubMed     Abstract available

  77. RAUCA VF, Licarete E, Luput L, Sesarman A, et al
    Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.
    PLoS One. 2018;13:e0202827.
    PubMed     Abstract available

  78. Correction: Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.
    PLoS One. 2018;13:e0204692.
    PubMed     Abstract available

  79. MARCHETTI CAUTELA J, Mannocci A, Reggiani C, Persechino F, et al
    Identifying the factors that influence surgeon's compliance with excisional margins of non-melanoma skin cancer.
    PLoS One. 2018;13:e0204330.
    PubMed     Abstract available

  80. KAZMIERCZAK PM, Burton NC, Keinrath G, Hirner-Eppeneder H, et al
    Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma.
    PLoS One. 2018;13:e0204930.
    PubMed     Abstract available

  81. RICHTIG G, Hoeller C, Wolf M, Wolf I, et al
    Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
    PLoS One. 2018;13:e0204729.
    PubMed     Abstract available

  82. Retraction: MicroRNA-143 Targets Syndecan-1 to Repress Cell Growth in Melanoma.
    PLoS One. 2018;13:e0205767.

  83. ISHIMURA ME, Teixeira D, Silveira GDP, Gambero M, et al
    Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.
    PLoS One. 2018;13:e0205148.
    PubMed     Abstract available

  84. DEBNIAK T, Scott RJ, Gorski B, Masojc B, et al
    BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population.
    PLoS One. 2018;13:e0204768.
    PubMed     Abstract available

  85. WIKSTROM JD, Lundeberg L, Frohm-Nilsson M, Girnita A, et al
    Differences in cutaneous melanoma treatment and patient satisfaction.
    PLoS One. 2018;13:e0205517.
    PubMed     Abstract available

  86. BEHRENS G, Niedermaier T, Berneburg M, Schmid D, et al
    Physical activity, cardiorespiratory fitness and risk of cutaneous malignant melanoma: Systematic review and meta-analysis.
    PLoS One. 2018;13:e0206087.
    PubMed     Abstract available

  87. SEYED JAFARI SM, Wiedmer C, Cazzaniga S, Frangez Z, et al
    Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.
    PLoS One. 2018;13:e0207019.
    PubMed     Abstract available

  88. SVEDMAN FC, Lohcharoenkal W, Bottai M, Brage SE, et al
    Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma.
    PLoS One. 2018;13:e0206942.
    PubMed     Abstract available

  89. POTEZ M, Trappetti V, Bouchet A, Fernandez-Palomo C, et al
    Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.
    PLoS One. 2018;13:e0206693.
    PubMed     Abstract available

  90. OHMI Y, Kambe M, Ohkawa Y, Hamamura K, et al
    Differential roles of gangliosides in malignant properties of melanomas.
    PLoS One. 2018;13:e0206881.
    PubMed     Abstract available

  91. JIANG Z, Cinti C, Taranta M, Mattioli E, et al
    Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
    PLoS One. 2018;13:e0206686.
    PubMed     Abstract available

  92. MURILLO JR, Kuras M, Rezeli M, Milliotis T, et al
    Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue.
    PLoS One. 2018;13:e0208562.
    PubMed     Abstract available

  93. KITANAKA N, Nakano R, Kitanaka T, Namba S, et al
    NF-kappaB p65 and p105 implicate in interleukin 1beta-mediated COX-2 expression in melanoma cells.
    PLoS One. 2018;13:e0208955.
    PubMed     Abstract available

  94. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0199249.
    PubMed     Abstract available

  95. Retraction: Green Tea Catechins Reduce Invasive Potential of Human Melanoma Cells by Targeting COX-2, PGE2 Receptors and Epithelial-to-Mesenchymal Transition.
    PLoS One. 2018;13:e0210345.

  96. Retraction: Silymarin Targets beta-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells.
    PLoS One. 2018;13:e0210344.

  97. MURILLO JR, Kuras M, Rezeli M, Miliotis T, et al
    Correction: Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue.
    PLoS One. 2018;13:e0210234.
    PubMed     Abstract available

  98. Retraction: Grape Seed Proanthocyanidins Inhibit Melanoma Cell Invasiveness by Reduction of PGE2 Synthesis and Reversal of Epithelial-to-Mesenchymal Transition.
    PLoS One. 2018;13:e0210343.

  99. BALERMPAS P, Stera S, Muller von der Grun J, Loutfi-Krauss B, et al
    Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    PLoS One. 2018;13:e0198692.
    PubMed     Abstract available

    Automated decision support in melanocytic lesion management.
    PLoS One. 2018;13:e0203459.
    PubMed     Abstract available

  101. AZIZOVA TV, Bannikova MV, Grigoryeva ES, Rybkina VL, et al
    Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates.
    PLoS One. 2018;13:e0205060.
    PubMed     Abstract available

  102. LEE JS, Mun JH
    Dermoscopy of venous lake on the lips: A comparative study with labial melanotic macule.
    PLoS One. 2018;13:e0206768.
    PubMed     Abstract available

    January 2017
  103. BINENBAUM Y, Ben-David G, Gil Z, Slutsker YZ, et al
    Cold Atmospheric Plasma, Created at the Tip of an Elongated Flexible Capillary Using Low Electric Current, Can Slow the Progression of Melanoma.
    PLoS One. 2017;12:e0169457.
    PubMed     Abstract available

  104. WANG JJ, Wu CC, Lee CL, Hsieh SL, et al
    Antimelanogenic, Antioxidant and Antiproliferative Effects of Antrodia camphorata Fruiting Bodies on B16-F0 Melanoma Cells.
    PLoS One. 2017;12:e0170924.
    PubMed     Abstract available

  105. ZAINULABADEEN A, Yao P, Zare H
    Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.
    PLoS One. 2017;12:e0170025.
    PubMed     Abstract available

  106. NIKOLOVSKA K, Spillmann D, Haier J, Ladanyi A, et al
    Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.
    PLoS One. 2017;12:e0170054.
    PubMed     Abstract available

  107. LABERGE GS, Duvall E, Grasmick Z, Haedicke K, et al
    A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis.
    PLoS One. 2017;12:e0168581.
    PubMed     Abstract available

  108. KONSTANTAKOU EG, Velentzas AD, Anagnostopoulos AK, Litou ZI, et al
    Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets.
    PLoS One. 2017;12:e0171512.
    PubMed     Abstract available

  109. SHAO C, Dai W, Li H, Tang W, et al
    The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
    PLoS One. 2017;12:e0171676.
    PubMed     Abstract available

  110. BAZIN M, Purohit NK, Shah GM
    Comprehensive measurement of UVB-induced non-melanoma skin cancer burden in mice using photographic images as a substitute for the caliper method.
    PLoS One. 2017;12:e0171875.
    PubMed     Abstract available

  111. XU G, Xue Y, Ozkurt ZG, Slimani N, et al
    Photoacoustic imaging features of intraocular tumors: Retinoblastoma and uveal melanoma.
    PLoS One. 2017;12:e0170752.
    PubMed     Abstract available

  112. WANG S, Fan W, Wan B, Tu M, et al
    Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    PLoS One. 2017;12:e0172498.
    PubMed     Abstract available

  113. SCHMIDT SA, Ording AG, Horvath-Puho E, Sorensen HT, et al
    Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
    PLoS One. 2017;12:e0171527.
    PubMed     Abstract available

  114. ECHTLER K, Konrad I, Lorenz M, Schneider S, et al
    Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
    PLoS One. 2017;12:e0172788.
    PubMed     Abstract available

  115. TUDOR D, Nenu I, Filip GA, Olteanu D, et al
    Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy.
    PLoS One. 2017;12:e0173241.
    PubMed     Abstract available

  116. Correction: Comprehensive measurement of UVB-induced non-melanoma skin cancer burden in mice using photographic images as a substitute for the caliper method.
    PLoS One. 2017;12:e0173718.
    PubMed     Abstract available

  117. WESSELS D, Lusche DF, Voss E, Kuhl S, et al
    Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.
    PLoS One. 2017;12:e0173400.
    PubMed     Abstract available

  118. LUO L, Orlow I, Kanetsky PA, Thomas NE, et al
    No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.
    PLoS One. 2017;12:e0174234.
    PubMed     Abstract available

  119. DEINLEIN T, Arzberger E, Zalaudek I, Massone C, et al
    Dermoscopic characteristics of melanoma according to the criteria "ulceration" and "mitotic rate" of the AJCC 2009 staging system for melanoma.
    PLoS One. 2017;12:e0174871.
    PubMed     Abstract available

  120. HAN X, Han Y, Zheng Y, Sun Q, et al
    Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo.
    PLoS One. 2017;12:e0175950.
    PubMed     Abstract available

  121. RITSMA L, Dey-Guha I, Talele N, Sole X, et al
    Integrin beta1 activation induces an anti-melanoma host response.
    PLoS One. 2017;12:e0175300.
    PubMed     Abstract available

  122. LEE BH, Neela PH, Kent MS, Zehnder AM, et al
    IQGAP1 is an oncogenic target in canine melanoma.
    PLoS One. 2017;12:e0176370.
    PubMed     Abstract available

  123. WELINDER C, Pawlowski K, Szasz AM, Yakovleva M, et al
    Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    PLoS One. 2017;12:e0176167.
    PubMed     Abstract available

  124. SHEEN YS, Liao YH, Lin MH, Chen JS, et al
    Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan.
    PLoS One. 2017;12:e0177126.
    PubMed     Abstract available

  125. HARTUNG N, Huynh CT, Gaudy-Marqueste C, Flavian A, et al
    Study of metastatic kinetics in metastatic melanoma treated with B-RAF inhibitors: Introducing mathematical modelling of kinetics into the therapeutic decision.
    PLoS One. 2017;12:e0176080.
    PubMed     Abstract available

  126. KEE JY, Han YH, Kim DS, Mun JG, et al
    beta-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.
    PLoS One. 2017;12:e0176937.
    PubMed     Abstract available

  127. NOGUCHI K, Dalton AC, Howley BV, McCall BJ, et al
    Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    PLoS One. 2017;12:e0177830.
    PubMed     Abstract available

  128. WU KJ, Huang JM, Zhong HJ, Dong ZZ, et al
    A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells.
    PLoS One. 2017;12:e0177123.
    PubMed     Abstract available

  129. JOHNSON CP, Kim IK, Esmaeli B, Amin-Mansour A, et al
    Systematic genomic and translational efficiency studies of uveal melanoma.
    PLoS One. 2017;12:e0178189.
    PubMed     Abstract available

  130. POPULO H, Batista R, Sampaio C, Pardal J, et al
    SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma.
    PLoS One. 2017;12:e0180392.
    PubMed     Abstract available

  131. URVANEGIA AC, Tavoloni Braga JC, Shitara D, Fregnani JH, et al
    Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry.
    PLoS One. 2017;12:e0179745.
    PubMed     Abstract available

  132. TRUCCO LD, Roselli E, Araya P, Nunez NG, et al
    Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.
    PLoS One. 2017;12:e0179897.
    PubMed     Abstract available

  133. WANG S, Fan W, Wan B, Tu M, et al
    Correction: Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    PLoS One. 2017;12:e0181129.
    PubMed     Abstract available

  134. PAYR S, Tichy B, Atteneder C, Michel M, et al
    Redifferentiation of aged human articular chondrocytes by combining bone morphogenetic protein-2 and melanoma inhibitory activity protein in 3D-culture.
    PLoS One. 2017;12:e0179729.
    PubMed     Abstract available

  135. CHEN J, Peng C, Lei L, Zhang J, et al
    Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility.
    PLoS One. 2017;12:e0183689.
    PubMed     Abstract available

  136. ZALESNA I, Osrodek M, Hartman ML, Rozanski M, et al
    Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro.
    PLoS One. 2017;12:e0183498.
    PubMed     Abstract available

  137. ZHAO X, Kong F, Wang L, Zhang H, et al
    c-FLIP and the NOXA/Mcl-1 axis participate in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells.
    PLoS One. 2017;12:e0184135.
    PubMed     Abstract available

  138. TARMANN L, Wackernagel W, Ivastinovic D, Schneider M, et al
    Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    PLoS One. 2017;12:e0183833.
    PubMed     Abstract available

  139. KIM HS, Shin MS, Cheon MS, Kim JW, et al
    GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.
    PLoS One. 2017;12:e0174565.
    PubMed     Abstract available

  140. NOBEYAMA Y, Nakagawa H
    Silencing of interferon regulatory factor gene 6 in melanoma.
    PLoS One. 2017;12:e0184444.
    PubMed     Abstract available

  141. MASUDA Y, Nakayama Y, Tanaka A, Naito K, et al
    Antitumor activity of orally administered maitake alpha-glucan by stimulating antitumor immune response in murine tumor.
    PLoS One. 2017;12:e0173621.
    PubMed     Abstract available

  142. ZHA L, He L, Xie W, Cheng J, et al
    Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.
    PLoS One. 2017;12:e0177964.
    PubMed     Abstract available

  143. GILMORE S
    Melanoma screening: Informing public health policy with quantitative modelling.
    PLoS One. 2017;12:e0182349.
    PubMed     Abstract available

  144. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Abstract available

  145. HULUR I, Skol AD, Gamazon ER, Cox NJ, et al
    Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.
    PLoS One. 2017;12:e0185730.
    PubMed     Abstract available

  146. BRASTER R, Grewal S, Visser R, Einarsdottir HK, et al
    Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
    PLoS One. 2017;12:e0177736.
    PubMed     Abstract available

  147. JASINSKA-KONIOR K, Pochylczuk K, Czajka E, Michalik M, et al
    Proton beam irradiation inhibits the migration of melanoma cells.
    PLoS One. 2017;12:e0186002.
    PubMed     Abstract available

  148. TERMINI JM, Gupta S, Raffa FN, Guirado E, et al
    Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.
    PLoS One. 2017;12:e0184915.
    PubMed     Abstract available

  149. NAKAMURA S, Kunikata T, Matsumoto Y, Hanaya T, et al
    Effects of a non-cyclodextrin cyclic carbohydrate on mouse melanoma cells: Characterization of a new type of hypopigmenting sugar.
    PLoS One. 2017;12:e0186640.
    PubMed     Abstract available

  150. MCWHIRTER SR, Duffy DL, Lee KJ, Wimberley G, et al
    Classifying dermoscopic patterns of naevi in a case-control study of melanoma.
    PLoS One. 2017;12:e0186647.
    PubMed     Abstract available

  151. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    PubMed     Abstract available

  152. CHEN LL, Zhu J, Schumacher J, Wei C, et al
    SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.
    PLoS One. 2017;12:e0184154.
    PubMed     Abstract available

  153. VANDEREYKEN M, Jacques S, Van Overmeire E, Amand M, et al
    Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
    PLoS One. 2017;12:e0185786.
    PubMed     Abstract available

  154. ZHENG X, Tang H, Zhao X, Sun Y, et al
    Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.
    PLoS One. 2017;12:e0184746.
    PubMed     Abstract available

  155. TIWARY S, Xu L
    Correction: FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells.
    PLoS One. 2017;12:e0187388.
    PubMed     Abstract available

  156. PEREZ EC, Xander P, Laurindo MFL, Novaes E Brito RR, et al
    The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes.
    PLoS One. 2017;12:e0187333.
    PubMed     Abstract available

  157. GAISER MR, Skorokhod A, Gransheier D, Weide B, et al
    Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.
    PLoS One. 2017;12:e0188602.
    PubMed     Abstract available

  158. GURAN R, Vanickova L, Horak V, Krizkova S, et al
    MALDI MSI of MeLiM melanoma: Searching for differences in protein profiles.
    PLoS One. 2017;12:e0189305.
    PubMed     Abstract available

  159. XU H, Gong J, Liu H
    High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
    PLoS One. 2017;12:e0189675.
    PubMed     Abstract available

  160. REIMER M, Denby E, Zustiak SP, Schober JM, et al
    Ras GAP-related and C-terminal domain-dependent localization and tumorigenic activities of IQGAP1 in melanoma cells.
    PLoS One. 2017;12:e0189589.
    PubMed     Abstract available

  161. MOLLERSEN K, Zortea M, Schopf TR, Kirchesch H, et al
    Comparison of computer systems and ranking criteria for automatic melanoma detection in dermoscopic images.
    PLoS One. 2017;12:e0190112.
    PubMed     Abstract available

    January 2016
  162. WU L, Hu Z, Huang Y, Yu Y, et al
    Radiation Changes the Metabolic Profiling of Melanoma Cell Line B16.
    PLoS One. 2016;11:e0162917.
    PubMed     Abstract available

  163. JIANG F, Jin K, Huang S, Bao Q, et al
    Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells.
    PLoS One. 2016;11:e0159849.
    PubMed     Abstract available

  164. LE TT, Skak K, Schroder K, Schroder WA, et al
    IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
    PLoS One. 2016;11:e0153975.
    PubMed     Abstract available

  165. GONZALES C, Yoshihara HA, Dilek N, Leignadier J, et al
    In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI.
    PLoS One. 2016;11:e0164557.
    PubMed     Abstract available

  166. VAN ESSEN TH, van Pelt SI, Bronkhorst IH, Versluis M, et al
    Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.
    PLoS One. 2016;11:e0164292.
    PubMed     Abstract available

  167. MISHRA PJ, Mishra PJ, Merlino G
    Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
    PLoS One. 2016;11:e0165102.
    PubMed     Abstract available

  168. YU J, Luo X, Huang H, Zhai Z, et al
    Clinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported Cases.
    PLoS One. 2016;11:e0165591.
    PubMed     Abstract available

  169. RODOLFO C, Rocco M, Cattaneo L, Tartaglia M, et al
    Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma Cells.
    PLoS One. 2016;11:e0167672.
    PubMed     Abstract available

  170. TOBIO A, Alfonso A, Madera-Salcedo I, Botana LM, et al
    Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model.
    PLoS One. 2016;11:e0167572.
    PubMed     Abstract available

  171. KOMINA A, Palkina N, Aksenenko M, Tsyrenzhapova S, et al
    Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
    PLoS One. 2016;11:e0168229.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.